Reuters logo
BRIEF-Neovacs FY operating loss widens to 17.3‍​ million euros
March 30, 2017 / 4:21 PM / 8 months ago

BRIEF-Neovacs FY operating loss widens to 17.3‍​ million euros

March 30 (Reuters) - Neovacs SA:

* FY revenue ‍​0.4 million euros versus 1.2 million euros ($1.29 million) year ago

* FY operating loss of 17.3‍​ million euros versus loss of 11.3 million euros year ago

* FY net loss of ‍​13.9 million euros versus loss of 4.7 million euros year ago Source text for Eikon: Further company coverage: ($1 = 0.9325 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below